Most Serious Warnings Product can cause: Severe allergic reactions, including rash, hives, swelling of the face, lips, tongue, or throat Bronchospasm or difficulty breathing Liver or kidney toxicity in rare cases Neurological symptoms or nervous system toxicity in rare cases Interactions with certain medications, including chemotherapeutic agents Compounded glutathione may carry sterility or formulation risks due to limited FDA oversight
Adjustments to meal size, timing, and food choices can make a noticeable difference in how your body responds to treatment
The Phase 2 trial showed 24.2% weight loss at 48 weeks, and Phase 3 data suggests 28.7% at 68 weeks
For research applications, BPC-157 should be stored as a lyophilized powder at -20C, where it remains stable for 24+ months